Absence of Functional and Structural Abnormalities Associated with Expression of EGFP in the Retina

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 1, 2004, Pages 15-22

  Nour, May ^a   Quiambao, Alexander B ^b   Al Ubaidi, Muayyad R ^a,b   Naash, Muna I ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FLUORESCENCE MICROSCOPY; GENETIC TRANSDUCTION; LIGHT EXPOSURE; MOUSE; NIGHT VISION; NONHUMAN; PHOTOPIC VISION; PRIORITY JOURNAL; RETINA; VIRAL GENE THERAPY;

ANIMALS; DARK ADAPTATION; ELECTRORETINOGRAPHY; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PHOTIC STIMULATION; PHOTORECEPTORS, VERTEBRATE; PHOTOTRANSDUCTION; RETINA; SAFETY;

EID: 0347358078     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0663     Document Type: Article

References (56)

1. Prasher DC, Eckenrode VK, Ward WW, et al. Primary structure of the Aequorea victoria green-fluorescent protein. Gene. 1992;111:229-233.
2. Chaffie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science. 1994;263:802-805.
3. Stone LM, Wilcox CL, Kinnamon SC. Virus-mediated transfer of foreign DNA into taste receptor cells. Chem Senses. 2002;27:779-787.
4. Neuner-Jehle M, Berghe LV, Bonnel S, et al. Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats. Hum Gene Ther. 2000;11:1875-1890.
5. Young AT, Lakey JR, Murray AG, et al. Gene therapy: a lipofection approach for gene transfer into primary endothelial cells. Cell Transplant. 2002;11:573-582.
6. Indraccolo S, Habeler W, Tisato V, et al. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Cancer Res. 2002;62:6099-6107.
7. Lu C, Albano CR, Bentley WE, et al. Differential rates of gene expression monitored by green fluorescent protein. Biotechnol Bioeng. 2002;79:429-437.
8. Lai CC, Gouras P, Doi K, et al. Tracking RPE transplants labeled by retroviral gene transfer with green fluorescent protein. Invest Ophthalmol Vis Sci. 1999;40:2141-2146.
9. Wang F, Xia X, Hu H, et al. Liposome-mediated gene transfer into retina [in Chinese]. Chung Hua Yen Ko Tsa Chih. 2002;38:520-522.
10. Takahashi K, Luo T, Saishin Y, et al. Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum Gene Ther. 2002;13:1305-1316.
11. Akimoto M, Miyatake S, Kogishi J, et al. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci. 1999;40:273-279.
12. Yu D, Chen D, Chiu C, et al. Prostate-specific targeting using PSA promoter-based lentiviral vectors. Cancer Gene Ther. 2001;8:628-635.
13. Yu YA, Szalay AA. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo. Mol Genet Genomics. 2002;268:169-178.
14. Marodon G, Mouly E, Blair EJ, et al. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood. 2003;101:3416-3423.
15. Zhao-Emonet JC, Marodon G, Pioche-Durieu C, et al. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer. J Gene Med. 2000;2:416-425.
16. Moto K, Kojima H, Kurihara M, et al. Cell-specific expression of enhanced green fluorescence protein under the control of neuropeptide gene promoters in the brain of the silkworm, Bombyx mori, using Bombyx mori nucleopolyhedrovirus-derived vectors. Insect Biochem Mol Biol. 2003;33:7-12.
17. Suzuki A, Obi K, Urabe T, et al. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem. 2002;82:953-960.
18. Grove JE, Lutzko C, Priller J, et al. Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol. 2002;27:645-651.
19. Leimig T, Mann L, Martin MP, et al. Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood. 2002;99:3169-3178.
20. Kitagawa M, Aizawa S, Sado T, et al. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts. Leukemia. 2001;15:1779-1784.
21. Mazurier F, Geronimi F, Lamrissi-Garcia I, et al. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria. Mol Ther. 2001;3:411-417.
22. Akamatsu W, Okano H. Neural stem cell, as a source of graft material for transplantation in neuronal disease. No To Hattatsu. 2001;33:114-120.
23. Cashman SM, Sadowski SL, Morris DJ, et al. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors-implications for gene therapy. Mol Ther. 2002;6:813-823.
24. Bainbridge JW, Stephens C, Parsley K, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 2001;8:1665-1668.
25. Sarra GM, Stephens C, De Alwis M, et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet. 2001;10:2353-2361.
26. Auricchio A, Kobinger G, Anand V, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet. 2001;10:3075-3081.
27. Liang FQ, Aleman TS, Dejneka NS, et al. Long-term protection of retinal structure but not function using RAAV: CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001;4:461-472.
28. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl. Acad Sci USA. 1999;96:9920-9925.
29. Miyoshi H, Takahashi M, Gage FH, et al. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997;94:10319-10323.
30. Luo Y, Chen X, Szilvasi A, et al. Co-expression of interleukin-2 and green fluorescent protein reporter in mycobacteria: in vivo application for monitoring antimycobacterial immunity. Mol Immunol. 2000;37:527-536.
31. Kawakami N, Sakane N, Nishizawa F, et al. Green fluorescent protein-transgenic mice: immune functions and their application to studies of lymphocyte development. Immunol Lett. 1999;70:165-171.
32. Doi, K, Hargitai J, Kong J, et al. Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection. Vision Res. 2002;42:551-558.
33. Stripecke R, Carmen VM, Skelton D, et al. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 1999;6:1305-1312.
34. Hanazono Y, Terao K, Shibata H, et al. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates. J Gene Med. 2002;4:470-477.
35. Narfstrom K, Katz ML, Bragadottir R, et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci. 2003;44:1663-1672.
36. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
37. Tan E, Wang Q, Quiambao AB, et al. The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2001;42:589-600.
38. Organisciak DT, Jiang YL, Wang HM, et al. Retinal light damage in rats exposed to intermittent light: comparison with continuous light exposure. Invest Ophthalmol Vis Sci. 1989;30:795-805.
39. Organisciak DT, Darrow RM, Barsalou L, et al. Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci. 1998;39:1107-1116.
40. Aonuma H, Yamazaki R, Watanabe I. Retinal cell death by light damage. Jpn J Ophthalmol. 1999;43:171-179.
41. Stone J, Maslim J, Valter-Kocsi K, et al. Mechanisms of photoreceptor death and survival in mammalian retina. Prog Retin Eye Res. 1999;18:689-735.
42. Sugawara T, Sieving PA, Bush RA. Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats. Exp Eye Res. 2000;70:693-705.
43. Hubbard R. Absorption spectrum of rhodopsin: 500 nm absorption band. Nature. 1969;221:432-435.
44. Ross RT. Absorption band shape and emission in rhodopsin. Photochem Photobiol. 1970;12:261-268.
45. Okabe M, Ikawa M, Kominami K, et al. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
46. Naash MI, Hollyfield JG, Al-Ubaidi MR, Baehr W. Simulation of human ADRP in transgenic mice expressing a mutated murine opsin gene. Proc Nat Acad Sci USA. 1993;90:5499-5503.
47. LaVail MM, Gorrin GM, Repaci MA, Yasumura D. Light-induced retinal degeneration in albino mice and rats: strain and species differences. Prog Clin Biol Res. 1987;247:439-454.
48. Wang M, Lam TT, Tso MO, et al. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis Neurosci. 1997;14:55-62.
49. Sieving PA, Richards JE, Naarendorp F, et al. Dark-light: model for nightblindness from the human rhodopsin Gly-90 →Asp mutation. Proc Natl Acad Sci USA. 1995;92:880-884.
50. Sieving PA, Fowler ML, Bush RA, et al. Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for, human congenital nightblindness without rod cell loss. J Neurosci. 2001;21:5449-5460.
51. Rao VR, Cohen GB, Oprian DD. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature. 1994;367:639-642.
52. Qtaishat NM, Okajima TI, Li S, et al. Retinoid kinetics in eye tissues of VPP transgenic mice and their normal littermates. Invest Ophthalmol Vis Sci. 1999;40:1040-1049.
53. Hafezi F, Grimm C, Simmen BC, et al. Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies. Br J Ophthalmol. 2000;84:922-927.
54. Bennett J, Tanabe T, Sun D, et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med. 1996;2:649-654.
55. Jomary C, Vincent KA, Grist J, et al. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther. 1997;4:683-690.
56. LaVail MM, Yasumura D, Matthes MT, et al. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci USA. 2000;97:11488-11493.